Results 231 to 240 of about 531,735 (303)

ALDH2 Suppresses Ferroptosis and Promotes Bortezomib Resistance in Multiple Myeloma Through the KEAP1‐NRF2 Feedback Loop

open access: yesAdvanced Science, EarlyView.
ALDH2, which is overexpressed in multiple myeloma, competitively binds KEAP1 to stabilize NRF2 by blocking its ubiquitin‐proteasomal degradation. Stabilized NRF2 translocates into the nucleus to upregulate the expression of GPX4. In parallel, NRF2 binds to the ALDH2 promoter to regulate its transcription, forming a positive feedback loop that represses
Ruonan Shao   +10 more
wiley   +1 more source

Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High-Altitude Regions of China. [PDF]

open access: yesCancer Innov
Li Y   +49 more
europepmc   +1 more source

Updated dosimetric comparison of HDR interventional radiotherapy including <sup>60</sup>Co sources versus VMAT and electron beam therapy for NMSC. [PDF]

open access: yesRadiat Environ Biophys
Sajjad S   +8 more
europepmc   +1 more source

An intractable case of primary intra-axial central nervous system Rosai-Dorfman disease. [PDF]

open access: yesSurg Neurol Int
Fujinaga A   +7 more
europepmc   +1 more source

Significance of adjuvant external beam radiotherapy of the orbit in managing uveal melanoma with extraocular extension. [PDF]

open access: yesBMJ Open Ophthalmol
Düsberg NC   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Dosage-rate in Radiotherapy

The British Journal of Radiology, 1944
Since this paper will be concerned mainly with experimental studies of the influence of dosage-rate on the response of isolated tissues, cells, and the component parts of cells, to ionizing radiations, it may be well to emphasise at the outset that the problem which presents itself to the radiotherapist wishing to make the best use of the time factor ...
  +5 more sources

Home - About - Disclaimer - Privacy